Johnson & Johnson Requests Authorization for a Booster dose of its Anti-Covid Vaccine

Pharmaceutical group Johnson & Johnson announced on Tuesday that it had submitted data to the United States Medicines Agency (FDA) for authorization for a booster injection in adults of its…

Read More

“If you Get a Janssen Vaccine your Antibody level will Increase 9 Times”

American pharmaceutical company Johnson & Johnson (J&J) announced on the 25th (local time) that the level of antibody was found to increase significantly when receiving a booster shot (boost shot)…

Read More

Spanish Joaquin Duato will be the New CEO of Johnson & Johnson

The current president and CEO of the company, Alex Gorsky, will leave his position on January 3, 2022. He has indicated that it is the most appropriate time to carry…

Read More

Shares of Johnson & Johnson Rose 1.3%

Johnson & Johnson shares were up 1.3 percent. They were responding to an assessment by the US Food and Drug Administration, according to which the pharmaceutical company’s corona vaccine, which…

Read More

FDA, J&J Vaccine Imminent Approval “Safe And Effective”

The US Food and Drug Administration (FDA) acknowledged the preventive effect and safety of the Johnson & Johnson (J&J) Covid- 19 vaccine on the 24th Johnson & Johnson requested the…

Read More

Johnson & Johnson Corona 19 Aşı Onayı İçin Başvurdu

Johnson & Johnson, 4’te şirketin bağlı kuruluşu Janssen Biotech‘in bir kez uygulanan “Corona 19” aşı adayı için FDA’ya “Acil Kullanım Onayı” (EUA) başvurusunda bulunduğunu duyurdu. “Acil kullanım onayı” başvurusu, 3….

Read More

Johnson & Johnson Covid-19 Vaccine Trial Interrupted due to Sick Participant

The pharmaceutical group Johnson & Johnson announced on Monday the suspension of its clinical trial of a vaccine against Covid-19, one of the participants having fallen ill. “We have temporarily…

Read More

Vaccine: Johnson & Johnson” Stimulates A Strong Immune Response to Prevent Corona

Provisional results, published Friday, showed that a single dose of an experimental Covid-19 vaccine stimulated a strong immune response to prevent the disease in an early to medium-stage clinical trial….

Read More

Johnson & Johnson: “2021 Nisan Ayında 600-800 Milyon Koronavirüs Aşısı Hazır”

Johnson & Johnson (J & J), klinik çalışma başarılı olursa, önümüzdeki yıl Nisan ayına kadar 900 milyon doz koronavirüs (Corona 19) aşısı üretebileceğini açıkladı. Firma Eylül ayında yapılması planlanan klinik…

Read More

Johnson & Johnson will Have 600-900 Million Coronavirus Vaccines by 2021

Johnson & Johnson (J & J) predicts that if the clinical trial is successful, it will be able to produce 900 million doses of new coronavirus (Corona 19) vaccine by…

Read More

Koronavirus Aşısı Bulundu Değeri 1 Milyar Dolar

Hülya Karahan: Production Editor istanbulpostcomtr@gmail.com Johnson & Johnson (J&J) şirketi, klinik öncesi araştırmaların ardından COVID-19 aşısı için aday gösterildiğini açıkladı. Birden fazla akademik kurumdaki bilim insanlarıyla yapılan işbirlikleri sayesinde, J&J’nin…

Read More

Page 1 of 1